Niche anchorage and signaling through membranebound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4441-4456

  Tabone Eglinger, Séverine ^a,c   Calderin Sollet, Zuleika ^a   Pinon, Perrine ^a   Aebischer, Nicole ^a   Wehrle Haller, Monique ^a   Jacquier, Marie Claude ^a   Boettiger, David ^b   Wehrle Haller, Bernhard ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Adhesion and spreading; Fibronectin; Integrin; Mast cells; Stem cell factor

Indexed keywords

BLOCKING ANTIBODY; F ACTIN; FIBRONECTIN; IMATINIB; INTEGRIN; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; ACTIN; BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN BINDING; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL ADHESION; CELL ANCHORAGE; CONTROLLED STUDY; DISSOCIATION; DRUG SENSITIVITY; ENZYME INHIBITION; FIBROBLAST; IN VITRO STUDY; INTRACELLULAR SIGNALING; MAST CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN STABILITY; SHEAR STRESS; STEM CELL NICHE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ACTINS; ANIMALS; BENZAMIDES; CELL ADHESION; CELL MOVEMENT; CELLULAR MICROENVIRONMENT; CERCOPITHECUS AETHIOPS; COS CELLS; FIBROBLASTS; INTEGRINS; MAST CELLS; MICE; PHOSPHORYLATION; PIPERAZINES; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 84907707634     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-249425     Document Type: Article

References (63)

1. Lennartsson, J., and Ronnstrand, L. (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 92, 1619-1649
2. DiNitto, J. P., Deshmukh, G. D., Zhang, Y., Jacques, S. L., Coli, R., Worrall, J. W., Diehl, W., English, J. M., and Wu, J. C. (2010) Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance. J. Biochem. 147, 601-609
3. Mol, C. D., Dougan, D. R., Schneider, T. R., Skene, R. J., Kraus, M. L., Scheibe, D. N., Snell, G. P., Zou, H., Sang, B. C., and Wilson, K. P. (2004) Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J. Biol. Chem. 279, 31655-31663
4. Mol, C. D., Lim, K. B., Sridhar, V., Zou, H., Chien, E. Y., Sang, B. C., Nowakowski, J., Kassel, D. B., Cronin, C. N., and McRee, D. E. (2003) Structure of a c-kit product complex reveals the basis for kinase transactivation. J. Biol. Chem. 278, 31461-31464
5. Deininger, M., Buchdunger, E., and Druker, B. J. (2005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640-2653
6. Ma, Y., Zeng, S., Metcalfe, D. D., Akin, C., Dimitrijevic, S., Butterfield, J. H., McMahon, G., and Longley, B. J. (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99, 1741-1744
7. Corbin, A. S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M. W., and Druker, B. J. (2011) Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121, 396-409
8. Flanagan, J. G., Chan, D. C., and Leder, P. (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64, 1025-1035
9. Huang, E. J., Nocka, K. H., Buck, J., and Besmer, P. (1992) Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell. 3, 349-362
10. Brannan, C. I., Lyman, S. D., Williams, D. E., Eisenman, J., Anderson, D. M., Cosman, D., Bedell, M. A., Jenkins, N. A., and Copeland, N. G. (1991) Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc. Natl. Acad. Sci. U.S.A. 88, 4671-4674
11. Wehrle-Haller, B., and Weston, J. A. (1995) Soluble and cellbound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. Development 121, 731-742
12. Toksoz, D., Zsebo, K. M., Smith, K. A., Hu, S., Brankow, D., Suggs, S. V., Martin, F. H., and Williams, D. A. (1992) Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membranebound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc. Natl. Acad. Sci. U.S.A. 89, 7350-7354
13. Miyazawa, K., Williams, D. A., Gotoh, A., Nishimaki, J., Broxmeyer, H. E., and Toyama, K. (1995) Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85, 641-649
14. Yee, N. S., Hsiau, C. W., Serve, H., Vosseller, K., and Besmer, P. (1994) Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3=-kinase, and protein kinase C. J. Biol. Chem. 269, 31991-31998
15. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., and Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637
16. Tabone-Eglinger, S., Wehrle-Haller, M., Aebischer, N., Jacquier, M. C., and Wehrle-Haller, B. (2012) Membrane-bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche. FASEB J. 26, 3738-3753
17. Ding, L., Saunders, T. L., Enikolopov, G., and Morrison, S. J. (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462
18. Papayannopoulou, T., Priestley, G. V., Nakamoto, B., Zafiropoulos, V., and Scott, L. M. (2001) Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood 98, 2403-2411
19. Dastych, J., and Metcalfe, D. D. (1994) Stem cell factor induces mast cell adhesion to fibronectin. J. Immunol. 152, 213-219
20. Kinashi, T., and Springer, T. A. (1994) Steel factor and c-kit regulate cell-matrix adhesion. Blood 83, 1033-1038
21. Nishikawa, S., Kusakabe, M., Yoshinaga, K., Ogawa, M., Hayashi, S., Kunisada, T., Era, T., and Sakakura, T. (1991) In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J. 10, 2111-2118
22. Wehrle-Haller, B. (2007) Analysis of integrin dynamics by fluorescence recovery after photobleaching. Methods Mol. Biol. 370, 173-202
23. Boettiger, D. (2007) Quantitative measurements of integrinmediated adhesion to extracellular matrix. Methods Enzymol. 426, 1-25
24. Paulhe, F., Wehrle-Haller, M., Jacquier, M. C., Imhof, B. A., Tabone-Eglinger, S., and Wehrle-Haller, B. (2009) Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain. FASEB J. 23, 3037-3048
25. Resnick, N., Yahav, H., Shay-Salit, A., Shushy, M., Schubert, S., Zilberman, L. C., and Wofovitz, E. (2003) Fluid shear stress and the vascular endothelium: for better and for worse. Prog. Biophys. Mol. Biol. 81, 177-199
26. Nocka, K., Tan, J. C., Chiu, E., Chu, T. Y., Ray, P., Traktman, P., and Besmer, P. (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9, 1805-1813
27. Tan, J. C., Nocka, K., Ray, P., Traktman, P., and Besmer, P. (1990) The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247, 209-212
28. Serve, H., Yee, N. S., Stella, G., Sepp-Lorenzino, L., Tan, J. C., and Besmer, P. (1995) Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14, 473-483
29. Fehlner-Gardiner, C. C., Uniyal, S., von Ballestrem, C. G., and Chan, B. M. (1996) Differential utilization of VLA-4 (alpha 4 beta 1) and -5 (alpha 5 beta 1) integrins during the development of mouse bone marrow-derived mast cells. Differentiation 60, 317-325
30. Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco- Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., Lio, P., Macdonald, H. R., and Trumpp, A. (2008) Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129
31. Barker, J. E. (1997) Early transplantation to a normal microenvironment prevents the development of Steel hematopoietic stem cell defects. Exp. Hematol. 25, 542-547
32. Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., Mar, J. C., Bergman, A., and Frenette, P. S. (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637-643
33. Parmar, K., Mauch, P., Vergilio, J. A., Sackstein, R., and Down, J. D. (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. U.S.A. 104, 5431-5436
34. Comb, W. C., Hutti, J. E., Cogswell, P., Cantley, L. C., and Baldwin, A. S. (2012) p85alpha SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation. Mol. Cell 45, 719-730
35. Nishimura, E. K., Jordan, S. A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I. J., Barrandon, Y., Miyachi, Y., and Nishikawa, S. (2002) Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854-860
36. Trumpp, A., Essers, M., and Wilson, A. (2010) Awakening dormant haematopoietic stem cells. Nat. Rev. Immunol. 10, 201-209
37. To, L. B., Haylock, D. N., Dowse, T., Simmons, P. J., Trimboli, S., Ashman, L. K., and Juttner, C. A. (1994) A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84, 2930-2939
38. Papayannopoulou, T., Priestley, G. V., and Nakamoto, B. (1998) Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 91, 2231-2239
39. Cabrita, M. A., Jaggi, F., Widjaja, S. P., and Christofori, G. (2006) A functional interaction between sprouty proteins and caveolin- 1. J. Biol. Chem. 281, 29201-29212
40. Mancini, A., Koch, A., Stefan, M., Niemann, H., and Tamura, T. (2000) The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity. FEBS Lett. 482, 54-58
41. Azam, M., Latek, R. R., and Daley, G. Q. (2003) Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112, 831-843
42. Zhang, J., Adrian, F. J., Jahnke, W., Cowan-Jacob, S. W., Li, A. G., Iacob, R. E., Sim, T., Powers, J., Dierks, C., Sun, F., Guo, G. R., Ding, Q., Okram, B., Choi, Y., Wojciechowski, A., Deng, X., Liu, G., Fendrich, G., Strauss, A., Vajpai, N., Grzesiek, S., Tuntland, T., Liu, Y., Bursulaya, B., Azam, M., Manley, P. W., Engen, J. R., Daley, G. Q., Warmuth, M., and Gray, N. S. (2010) Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 463, 501-506
43. Martino, M. M., Tortelli, F., Mochizuki, M., Traub, S., Ben-David, D., Kuhn, G. A., Muller, R., Livne, E., Eming, S. A., and Hubbell, J. A. (2011) Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra189
44. Martino, M. M., Briquez, P. S., Ranga, A., Lutolf, M. P., and Hubbell, J. A. (2013) Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc. Natl. Acad. Sci. U.S.A. 110, 4563-4568
45. Salaita, K., Nair, P. M., Petit, R. S., Neve, R. M., Das, D., Gray, J. W., and Groves, J. T. (2010) Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380-1385
46. Paszek, M. J., Boettiger, D., Weaver, V. M., and Hammer, D. A. (2009) Integrin clustering is driven by mechanical resistance from the glycocalyx and the substrate. PLoS Comput. Biol. 5, e1000604
47. Beghini, A., Tibiletti, M. G., Roversi, G., Chiaravalli, A. M., Serio, G., Capella, C., and Larizza, L. (2001) Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92, 657-662
48. Maeyama, H., Hidaka, E., Ota, H., Minami, S., Kajiyama, M., Kuraishi, A., Mori, H., Matsuda, Y., Wada, S., Sodeyama, H., Nakata, S., Kawamura, N., Hata, S., Watanabe, M., Iijima, Y., and Katsuyama, T. (2001) Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene. Gastroenterology 120, 210-215
49. Robson, M. E., Glogowski, E., Sommer, G., Antonescu, C. R., Nafa, K., Maki, R. G., Ellis, N., Besmer, P., Brennan, M., and Offit, K. (2004) Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia. Clin. Cancer Res. 10, 1250-1254
50. Sommer, G., Agosti, V., Ehlers, I., Rossi, F., Corbacioglu, S., Farkas, J., Moore, M., Manova, K., Antonescu, C. R., and Besmer, P. (2003) Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc. Natl. Acad. Sci. U.S.A. 100, 6706-6711
51. Kimura, Y., Jones, N., Kluppel, M., Hirashima, M., Tachibana, K., Cohn, J. B., Wrana, J. L., Pawson, T., and Bernstein, A. (2004) Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc. Natl. Acad. Sci. U.S.A. 101, 6015-6020
52. Scheijen, B., and Griffin, J. D. (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 21, 3314-3333
53. Agosti, V., Corbacioglu, S., Ehlers, I., Waskow, C., Sommer, G., Berrozpe, G., Kissel, H., Tucker, C. M., Manova, K., Moore, M. A., Rodewald, H. R., and Besmer, P. (2004) Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J. Exp. Med. 199, 867-878
54. Agosti, V., Karur, V., Sathyanarayana, P., Besmer, P., and Wojchowski, D. M. (2009) A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis. Exp. Hematol. 37, 159-171
55. Dastych, J., Taub, D., Hardison, M. C., and Metcalfe, D. D. (1998) Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis. Am. J. Physiol. 275, C1291-C1299
56. Waskow, C., Bartels, S., Schlenner, S. M., Costa, C., and Rodewald, H. R. (2007) Kit is essential for PMA-inflammationinduced mast-cell accumulation in the skin. Blood 109, 5363-5370
57. Adachi, S., Ebi, Y., Nishikawa, S., Hayashi, S., Yamazaki, M., Kasugai, T., Yamamura, T., Nomura, S., and Kitamura, Y. (1992) Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 79, 650-656
58. Fewkes, N. M., Krauss, A. C., Guimond, M., Meadors, J. L., Dobre, S., and Mackall, C. L. (2010) Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood 115, 4120-4129
59. Vermeulen, L., de Sousa e Melo, F., Richel, D. J., and Medema, J. P. (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 13, e83-89
60. Michor, F., Hughes, T. P., Iwasa, Y., Branford, S., Shah, N. P., Sawyers, C. L., and Nowak, M. A. (2005) Dynamics of chronic myeloid leukaemia. Nature 435, 1267-1270
61. Roeder, I., Horn, M., Glauche, I., Hochhaus, A., Mueller, M. C., and Loeffler, M. (2006) Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat. Med. 12, 1181-1184
62. Puissant, A., Dufies, M., Fenouille, N., Ben Sahra, I., Jacquel, A., Robert, G., Cluzeau, T., Deckert, M., Tichet, M., Cheli, Y., Cassuto, J. P., Raynaud, S., Legros, L., Pasquet, J. M., Mahon, F. X., Luciano, F., and Auberger, P. (2012) Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. J. Mol. Cell. Biol. 4, 207-220
63. Hoek, K. S., and Goding, C. R. (2010) Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759